| PRODUCT NAME: | AccuLite CA 19-9 |
| INTENDED USE: | The quantitative determination of Cancer Antigen 19-9 (CA 19-9) concentration in human serum by a Microplate Chemiliuminescense Immunoassay (CLIA). |
| PRODUCT OVERVIEW: | Cancer antigen 19-9 (CA 19-9) have been recognized as circulating cancer associated antigens for gastrointestinal cancer. Serum CA 19-9 level is frequently elevated in the circulation of patients with various gastrointestinal malignancies, such as pancreatic, colorectal, gastric and hepatic carcinomas. Together with CEA elevated CA 19-9 is suggestive of gallbladder disease. |
TECHNICAL SPECIFICATIONS:
|
| Method: | Enzyme Immunoassay, Chemiluminescense |
| Principle: | Sandwich Assay, Streptavidin-Coated Plate |
| Calibrators: | 0, 10, 50, 100, 250, 500 U/ml |
| Sample type: | Serum |
| Sample volume: | 25 µl
|
| Measuring range: | 0.04- 500 U/ml |
| Reading: | RLU's |
| Total time: | 80 minutes
|
| Storage: | 2 - 8ºC
|
| Kit Contents: | Human Serum References
CA 19-9 Tracer Reagent
CA 19-9 Biotin Reagent
Light Reaction Wells
Wash Solution Concentrate
Signal Reagent A
Signal Reagent B
|